In contrast, the distribution of the different subsets of BM BCP, mature (pre-GC and pos-GC) B-cells and nPC at day+100 post-ASCT, did not show a significant impact on PFS of MM patients, regardless of their BM MRD status (Figure 3B–D). This evidence concerns the gene OPN1SW and Miyoshi myopathy.